IL139951A0 - Basbo27 proteins and genes from moraxella catarrhalis, intigens, antibodies and uses - Google Patents

Basbo27 proteins and genes from moraxella catarrhalis, intigens, antibodies and uses

Info

Publication number
IL139951A0
IL139951A0 IL13995199A IL13995199A IL139951A0 IL 139951 A0 IL139951 A0 IL 139951A0 IL 13995199 A IL13995199 A IL 13995199A IL 13995199 A IL13995199 A IL 13995199A IL 139951 A0 IL139951 A0 IL 139951A0
Authority
IL
Israel
Prior art keywords
intigens
basbo27
genes
antibodies
proteins
Prior art date
Application number
IL13995199A
Other languages
English (en)
Original Assignee
Smithkline Beecham Biolog
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9811945.6A external-priority patent/GB9811945D0/en
Priority claimed from GBGB9905304.3A external-priority patent/GB9905304D0/en
Application filed by Smithkline Beecham Biolog filed Critical Smithkline Beecham Biolog
Publication of IL139951A0 publication Critical patent/IL139951A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • C07K14/212Moraxellaceae, e.g. Acinetobacter, Moraxella, Oligella, Psychrobacter
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL13995199A 1998-06-03 1999-05-31 Basbo27 proteins and genes from moraxella catarrhalis, intigens, antibodies and uses IL139951A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9811945.6A GB9811945D0 (en) 1998-06-03 1998-06-03 Novel compounds
GBGB9905304.3A GB9905304D0 (en) 1999-03-08 1999-03-08 Novel compounds
PCT/EP1999/003822 WO1999063093A2 (fr) 1998-06-03 1999-05-31 Proteines et genes basb027 de moraxella catarrhalis, antigenes, anticorps, et leurs utilisations

Publications (1)

Publication Number Publication Date
IL139951A0 true IL139951A0 (en) 2002-02-10

Family

ID=26313784

Family Applications (2)

Application Number Title Priority Date Filing Date
IL13995199A IL139951A0 (en) 1998-06-03 1999-05-31 Basbo27 proteins and genes from moraxella catarrhalis, intigens, antibodies and uses
IL139951A IL139951A (en) 1998-06-03 2000-11-28 27 BASBO proteins and genes from CATARRHALIS MORAXELLA, antigens, antibodies and uses

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL139951A IL139951A (en) 1998-06-03 2000-11-28 27 BASBO proteins and genes from CATARRHALIS MORAXELLA, antigens, antibodies and uses

Country Status (23)

Country Link
US (3) US6803043B1 (fr)
EP (1) EP1082435B1 (fr)
JP (1) JP4503177B2 (fr)
KR (3) KR100830282B1 (fr)
CN (1) CN1311820B (fr)
AT (1) ATE341628T1 (fr)
AU (1) AU738896B2 (fr)
BR (1) BR9911609A (fr)
CA (1) CA2331196A1 (fr)
CY (1) CY1105820T1 (fr)
CZ (1) CZ296086B6 (fr)
DE (1) DE69933444T2 (fr)
DK (1) DK1082435T3 (fr)
ES (1) ES2274627T3 (fr)
HK (1) HK1037209A1 (fr)
HU (1) HUP0102235A3 (fr)
IL (2) IL139951A0 (fr)
NO (1) NO327201B1 (fr)
NZ (1) NZ508617A (fr)
PL (1) PL198031B1 (fr)
PT (1) PT1082435E (fr)
TR (1) TR200003608T2 (fr)
WO (1) WO1999063093A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0103171D0 (en) 2001-02-08 2001-03-28 Smithkline Beecham Biolog Vaccine composition
WO2003040172A2 (fr) * 2001-11-09 2003-05-15 Aegera Therapeutics, Inc. Procedes et reactifs destines aux tamis par interaction peptides-bir
KR101239242B1 (ko) 2002-08-02 2013-03-11 글락소스미스클라인 바이오로지칼즈 에스.에이. 항원 조합물을 포함하는 나이세리아 백신 조성물
TWI457133B (zh) 2005-12-13 2014-10-21 Glaxosmithkline Biolog Sa 新穎組合物
WO2024017827A1 (fr) 2022-07-19 2024-01-25 Glaxosmithkline Biologicals Sa Procédé continu de production de vaccin

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9224584D0 (en) * 1992-11-23 1993-01-13 Connaught Lab Use of outer membrane protein d15 and its peptides as vaccine against haempohilus influenzae diseases
BE1006377A3 (fr) 1992-11-24 1994-08-09 Raffinerie Tirlemontoise Sa Procede de separation d'une composition polydispersee de saccharides, produits obtenus par ce procede et utilisation des produits obtenus dans des compositions alimentaires.
US5807978A (en) * 1995-06-07 1998-09-15 Kokolus; William J. Immunogenic peptides of prostate specific antigen
US6090576A (en) * 1996-03-08 2000-07-18 Connaught Laboratories Limited DNA encoding a transferrin receptor of Moraxella
US6673910B1 (en) * 1999-04-08 2004-01-06 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to M. catarrhalis for diagnostics and therapeutics

Also Published As

Publication number Publication date
US20040265331A1 (en) 2004-12-30
PL198031B1 (pl) 2008-05-30
NO20006112L (no) 2001-02-02
WO1999063093A2 (fr) 1999-12-09
DE69933444T2 (de) 2007-03-29
WO1999063093A3 (fr) 2000-03-02
PL345193A1 (en) 2001-12-03
US7641910B2 (en) 2010-01-05
CN1311820B (zh) 2011-11-16
KR100830282B1 (ko) 2008-05-16
DE69933444D1 (de) 2006-11-16
TR200003608T2 (tr) 2001-04-20
ES2274627T3 (es) 2007-05-16
NZ508617A (en) 2003-08-29
US6803043B1 (en) 2004-10-12
AU738896B2 (en) 2001-09-27
JP2002517199A (ja) 2002-06-18
KR100911277B1 (ko) 2009-08-11
HUP0102235A1 (hu) 2001-10-28
CZ296086B6 (cs) 2006-01-11
CY1105820T1 (el) 2011-02-02
EP1082435A2 (fr) 2001-03-14
CN1311820A (zh) 2001-09-05
CA2331196A1 (fr) 1999-12-09
NO327201B1 (no) 2009-05-11
BR9911609A (pt) 2001-02-06
JP4503177B2 (ja) 2010-07-14
ATE341628T1 (de) 2006-10-15
HUP0102235A3 (en) 2004-10-28
KR20010052552A (ko) 2001-06-25
PT1082435E (pt) 2007-01-31
NO20006112D0 (no) 2000-12-01
DK1082435T3 (da) 2007-02-05
US20100143412A1 (en) 2010-06-10
CZ20004510A3 (cs) 2001-07-11
KR20060129108A (ko) 2006-12-14
IL139951A (en) 2008-08-07
AU4373299A (en) 1999-12-20
HK1037209A1 (en) 2002-02-01
KR20070089890A (ko) 2007-09-03
EP1082435B1 (fr) 2006-10-04

Similar Documents

Publication Publication Date Title
AU3931599A (en) Basb019 proteins and genes from (moraxella catarrhalis), antigens, antibodies, and uses
IL139951A0 (en) Basbo27 proteins and genes from moraxella catarrhalis, intigens, antibodies and uses
IL139612A0 (en) Compounds from moraxella catarrhalis
ATE281524T1 (de) Moraxella catarrhalis pilq proteine
DE69928931D1 (de) Moraxella catarrhalis polynukleotide und polypeptide
AU6833000A (en) Basb118 polypeptide and polynucleotide from moraxella catarrhalis
AU6988700A (en) Basb119 polypeptide and polynucleotide from moraxella catarrhalis
AU4260299A (en) Basb028 polypeptides and polynucleotides encoding therefor from moraxella catarrhalis
HK1047954A1 (zh) 衍生自黏膜炎莫拉氏菌的免疫源性多肽及其用途
WO1999058682A3 (fr) Composes derives de moraxella catarrhalis
DE60019614D1 (de) Moraxella catarrhalis antigen basb117
WO2001009331A3 (fr) Nouveaux composes
HK1045331A1 (en) Basb111 polypeptide and polynucleotide from moraxella catharrhalis
DE60019613D1 (de) Moraxella catarrhalis antigen basb120
ATE368686T1 (de) Polypeptide aus moraxella (branhamella) catarrhalis
WO2001009330A3 (fr) Nouveaux composes
WO2001009337A3 (fr) Nouveaux composes

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed